Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
58 /100
HIGH RISK
Score updated Oct 13, 2026

RLMD — Relmada Therapeutics, Inc. Dilution Risk Tracker

Track RLMD dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track RLMD — Get alerts when the score changes →

As of October 13, 2026, Relmada Therapeutics, Inc. (RLMD) has a DilutionWatch DilutionScore of 58/100, rated HIGH dilution risk. Relmada Therapeutics, Inc. has a market capitalization of $374.41M, 106.67M shares outstanding, 106 institutional holders tracked. Stored dilution-related fields include ATM program capacity of $100.00M, 5.4K outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
80
💰 Cash Runway
0
📊 Float Risk
100
⚠️ Warrant Exposure
15
🔄 Convertible Debt
40

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 9%
💰 Capital Raise model 18%
• Active ATM program with $100M remaining capacity
🔔 Track RLMD — Get forecast alerts →

Market Data

Market Cap$374.41M
Shares Outstanding106.67M
Float7.72M
Cash$217.73M
Debt$110.2K
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore58/100DilutionWatch score record
Shares Outstanding106.67MVerified float table or market cache
Public Float7.72MVerified float table or market cache
Market Cap$374.41MMarket data cache
Cash Runway41.7 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM Capacity$100.00MSEC-derived dilution fields
Outstanding Warrants5.4KSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 4.

Recent SEC source mix: 424B5 1, 8-K 1, XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 100.1% shares (2026Q1 vs prior)
106 institutional holders · 102.62M shares
#1 JANUS HENDERSON GROUP PLC 22.13M shares
#2 Squadron Capital Management LLC 8.47M shares
#3 Spruce Street Capital LP 6.26M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest13.42M
Days to Cover13.0
% of Float173.9%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2025-11-13
xbrl XBRL CONVERTIBLE 2019-09-24
8-K 8K EVENT 2026-03-09
424B5 ATM 2026-01-30
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual RLMD Dilution Snapshot

Relmada Therapeutics, Inc. (RLMD) has a DilutionScore of 58/100, rated High dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

RLMD's DilutionScore has held steady at 58/100 (High risk) for 89 consecutive days across the tracked period.

Period Score Risk Level Duration
Jul 16 – Oct 13, 202658/100HIGH89 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

RLMD shares outstanding have increased 43.0% from 73.33M (Mar 2026) to 104.89M (Apr 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
Apr 03, 2026104.89M7.72M▼ 91.45%
Mar 27, 2026104.89M90.27M▲ 25.33%
Mar 25, 202673.33M72.02M▲ 43.03%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track RLMD Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment RLMD files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking RLMD — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for RLMD
RLMD FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.